Glokom Katarakt, cilt.17, sa.3, ss.118-123, 2022 (Hakemli Dergi)
Purpose: To evaluate effects of intracameral 2mg/0.1ml triamcinolone acetonide administered at the end of uncomplicated phacoemulsification
surgery on postoperative inflammation and intraocular pressure (IOP).
Materials and Methods: This prospective study included 50 eyes of 50 patients who underwent uncomplicated phacoemulsification surgery.
At the end of surgery, 2 mg/0.1ml of triamcinolone was injected into the anterior chamber in 26 eyes (Group A) while balanced salt solution
was administered to 24 eyes as placebo (Group B). Topical prednisolone acetate 1% treatment was given to the Group B postoperatively while
Group A did not receive any topical steroid therapy. Best corrected visual acuity, spherical and cylindrical refraction and IOP values as well as
degree of corneal edema and anterior chamber reaction were compared between groups on the postoperative day 1and week 1.
Results: There was no significant difference in IOP measured on postoperative day and week 1 between groups (p>0.05). In both groups, mean
IOP was higher on postoperative day 1 than preoperative IOP. The IOP increase was 1.6±6.0 mmHg in group A and 4.1±6.7 mmHg in group
B on postoperative day 1. There was no significant difference in IOP change on postoperative day 1 between groups (p=0.120). No significant
difference was found in degree of corneal edema and anterior chamber cell on postoperative day 1 and week 1 between groups (p>0.05).
Conclusion: After uncomplicated cataract surgery, 2mg/0.1ml intracameral triamcinolone injection was found to be as effective as topical 1%
prednisolone acetate in controlling postoperative inflammation.